Results 81 to 90 of about 17,680 (157)
Clinical and molecular response to vorasidenib in post-transplant patient with IDH2-mutant intrahepatic cholangiocarcinoma. [PDF]
Altiery De Jesus VV +6 more
europepmc +1 more source
Pecht Nantke
doaj +1 more source
Hundt Marianne
doaj +1 more source
Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study. [PDF]
El Zarif T +51 more
europepmc +1 more source
Schwarz-Friesel Monika
doaj +1 more source
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations. [PDF]
Nguyen MK +27 more
europepmc +1 more source
Schäfke Werner
doaj +1 more source
Immune checkpoint inhibitors in resectable and locoregionally advanced HNSCC: past lessons, present evidence, and future directions. [PDF]
Jeerapradit K, Keam B, Ngamphaiboon N.
europepmc +1 more source
Larsen Niels-Erik
doaj +1 more source
Molecular and immune correlates of lymphocyte activation gene-3 expression in renal cell carcinoma. [PDF]
Dudipala H +15 more
europepmc +1 more source

